Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.45 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.44 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3032498 | 0.89 | CYP1A2 (0.47) | TP53TSHR | |
| SCHEMBL2919381 | 0.86 | TP53 (0.51) | PLA2G4BTP53TSHRKMT2APLA2G4A | |
| SCHEMBL4946472 | 0.84 | PLA2G4B (0.46) | PLA2G4BPTPN11LTB4RPLA2G2ATP53 | |
| SCHEMBL19856520 | 0.83 | PLA2G4B (0.44) | PLA2G4BPTPN11LTB4RPLA2G2ATP53 | |
| SCHEMBL966260 | 0.80 | ALDH1A1 (0.60) | PTPN11TP53TSHRKMT2A | |
| Octane SCHEMBL28188569 | 0.79 | KDM4E (0.54) | PLA2G4BPTPN11LTB4RPLA2G2ATP53 | |
| Isophthalic Acid SCHEMBL11324134 | 0.78 | KMT2A (0.58) | PLA2G4BPTPN11PLA2G2ATP53TSHR | |
| SCHEMBL5503795 | 0.77 | LMNA (0.61) | PLA2G4BTP53TSHR | |
| SCHEMBL9115922 | 0.77 | LMNA (0.61) | PLA2G4BTP53TSHR | |
| SCHEMBL2918611 | 0.77 | LMNA (0.61) | PLA2G4BTP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3103788-B1 | PLASTICIZER COMPOSITION, METHOD FOR MANUFACTURING PLASTICIZER COMPOSITION, AND RESIN COMPOSITION COMPRISING PLASTICIZER COMPOSITION | LG CHEMICAL LTD (KR) | 2020-04-01 | — | — | EP | disclosed |
| US-10208185-B2 | Ester-based compound, plasticizer composition including the same, preparation method of the composition and resin composition including the plasticizer composition | LG CHEM, LTD. (KR) | 2019-02-19 | — | — | US | disclosed |
| US-20170166724-A1 | Ester-Based Compound, Plasticizer Composition Including the Same, Preparation Method of the Composition and Resin Composition Including the Plasticizer Composition | LG CHEM, LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
| EP-3103788-A1 | ESTER COMPOUND, PLASTICIZER COMPOSITION COMPRISING SAME, METHOD FOR MANUFACTURING PLASTICIZER COMPOSITION, AND RESIN COMPOSITION COMPRISING PLASTICIZER COMPOSITION | LG Chem, Ltd. (KR) | 2016-12-14 | — | — | EP | disclosed |
| US-8598060-B2 | Method of regenerating ruthenium catalysts for the ring hydrogenation of phthalates | BASF SE (DE) | 2013-12-03 | — | — | US | disclosed |
| US-20090305869-A1 | METHOD OF REGENERATING RUTHENIUM CATALYSTS FOR THE RING HYDROGENATION OF PHTHALATES | BASF (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166724-A1 | Ester-Based Compound, Plasticizer Composition Including the Same, Preparation Method of the Composition and Resin Composition Including the Plasticizer Composition | ELL, ELOVL1, ELP1 | PLA2G4B 2080/4885PTPN11 1745/4885LTB4R 260/4885 |
| US-10208185-B2 | Ester-based compound, plasticizer composition including the same, preparation method of the composition and resin composition including the plasticizer composition | ELL, ELOVL1, ELP1 | PLA2G4B 2080/4885PTPN11 1745/4885LTB4R 260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.